Edition:
United States

Neuca SA (NEUP.WA)

NEUP.WA on Warsaw Stock Exchange

230.50PLN
16 Nov 2018
Change (% chg)

-- (--)
Prev Close
230.50zł
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
3,318
52-wk High
316.50zł
52-wk Low
221.00zł

Chart for

About

Neuca SA is a Poland-based company engaged in the healthcare sector. The Company’s main activities comprise the wholesale of pharmaceuticals; running its own pharmacies under the brand name Synoptis Pharma; provision of advertising, marketing and information technology (IT) services to healthcare market, production of pharmaceut... (more)

Overall

Beta: 0.02
Market Cap(Mil.): zł1,087.65
Shares Outstanding(Mil.): 4.63
Dividend: 6.40
Yield (%): 2.72

Financials

  NEUP.WA Industry Sector
P/E (TTM): 11.44 21.85 30.22
EPS (TTM): 20.54 -- --
ROI: 15.71 10.70 54.20
ROE: 16.80 12.02 61.78

BRIEF-Neuca Offers To Buy Back 150,000 Of Own Shares

* OFFERS TO BUY BACK NO MORE THAN 150,000 OF CO'S SHARES REPRESENTING 3.24 PCT OF ITS SHARE CAPITAL FOR 235 ZLOTYS/SHARE

Nov 13 2018

BRIEF-Neuca Q3 Net Profit Up At 24.1 Mln Zlotys

* REPORTS Q3 NET PROFIT OF 24.1 MLN ZLOTYS VS 21.7 MLN ZLOTYS YEAR AGO

Nov 12 2018

BRIEF-Neuca Q2 Net Profit Rises To 18.5 Mln Zlotys

Aug 29 NEUCA SA: * Q2 NET PROFIT 18.5 MLN ZLOTYS VS 11.8 MLN ZLOTYS YEAR AGO * Q2 REVENUE 1.78 BLN ZLOTYS VS 1.78 BLN ZLOTYS YEAR AGO * Q2 OPER PROFIT 24.8 MLN ZLOTYS VS 16.1 MLN ZLOTYS YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Aug 29 2018

Earnings vs. Estimates